N/A N=3 Health Services Research

COVID-19 Close Contact Self-Testing Study

Covid19

Bottom Line

View on ClinicalTrials.gov: NCT04847479 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Feb 2025

Primary outcome: Primary: Number of Positive Contacts — 0; 0 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: COVID-19 self-test (Behavioral); COVID-19 test referral (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Pennsylvania
Primary completion: Nov 2023

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Positive Contacts	0; 0	—
SECONDARY Number of Positive Contacts (End of Study)	0; 0	—
SECONDARY Number of Contacts Tested	2	—
SECONDARY Number of Contacts Tested (End of Study)	0; 0	—
SECONDARY Number of Household Contacts Tested	0; 0	—
SECONDARY Number of Household Contacts Tested (End of Study)	0; 0	—

Summary

Widespread testing and contact tracing are critical to controlling the COVID-19 epidemic. Distribution of COVID-19 self-test kits can augment public health contact tracing efforts, as individuals with COVID-19 can distribute self-testing to close contacts. This approach can increase case detection by facilitating testing among exposed individuals, and potentially ameliorate stigma, fear, and medical mistrust associated with COVID-19 among vulnerable populations. The central hypothesis of this study is that distribution of SARS-CoV-2 self-tests to close contacts of among individuals with COVID-19 infection can increase case detection compared with a standard contact referral strategy.

Eligibility Criteria

Inclusion Criteria

18 years of age or older
Has a working telephone number
Willing and able to provide informed consent

Exclusion Criteria

Severe symptoms requiring immediate medical attention
Younger than 18 years of age
Does not have a working telephone number
Unable or unwilling to provide informed consent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04847479). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.